cGMP-4 Facility Commercialization with 3-Year Revenue Visibility
What: Commercial supplies commenced to European CDMO partner with strong revenue visibility over next three years
Impact: +₹127 Cr revenue
“During the quarter, we achieved a significant milestone with our European CDMO partner as we have successfully completed validation and commercial supplies as commenced from our cGMP-4 facility. This engagement provides strong revenue visibility over the next three years.”